The AstraZeneca COVID-19 shot is being withdrawn worldwide, months after the pharmaceutical company acknowledged for the first time in court documents the injection can cause blood clotting.

As 100 Percent Fed Up noted, the European Union’s (EU) European Commission announced the marketing authorization for AstraZeneca’s COVID-19 shot, upon the company’s request, had been withdrawn.

AstraZeneca COVID-19 Shot Marketing Authorization Officially Withdrawn In European Union

The decision was implemented on March 27, 2024, with the marketing authorization withdrawal going into effect on May 7, 2024.

The Guardian reports:

AstraZeneca has begun the worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” that target new variants of the virus.

The announcement follows the pharmaceutical company in March voluntarily withdrawing its European Union marketing authorisation, which is the approval to market a medicine in member states.

On 7 May, the European Medicines Agency issued a notice that the vaccine is no longer authorised for use.

In a statement, AstraZeneca said the decision was made because there is now a variety of newer vaccines available that have been adapted to target Covid-19 variants. This had led to a decline in demand for the AstraZeneca vaccine, which is no longer being manufactured or supplied.

“The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical giant admitted for the first time in court documents that it can cause a rare and dangerous side effect. The vaccine can no longer be used in the European Union, after the company voluntarily withdrew its ‘marketing authorization.’ The application to withdraw the vaccine was made on March 5 and came into effect on Tuesday," Chief Nerd wrote, citing The Telegraph.

"The decision to withdraw it brings to an end the use of the jab, which was heralded by Boris Johnson as a ‘triumph for British science’ and credited with saving more than six million lives," he added.

From The Telegraph:

AstraZeneca said the vaccine was being removed from markets for commercial reasons. It said the vaccine was no longer being manufactured or supplied, having been superseded by updated vaccines that tackle new variants.

Vaxzevria has come under intense scrutiny in recent months over a very rare side effect, which causes blood clots and low blood platelet counts. AstraZeneca admitted in court documents lodged with the High Court in February that the vaccine “can, in very rare cases, cause TTS”.

TTS – which stands for Thrombosis with Thrombocytopenia Syndrome – has been linked to at least 81 deaths in the UK as well as hundreds of serious injuries. AstraZeneca is being sued by more than 50 alleged victims and grieving relatives in a High Court case.

"AstraZeneca faces up to £255million compensation bill for 'defective' Covid vaccine after pharma titan admitted it DOES cause ultra-rare blood clot side effect," Daily Mail stated.

Per Daily Mail:

More than £250million could be given to victims allegedly harmed by AstraZeneca's Covid vaccine, MailOnline can reveal today.

Fifty-one families are pursuing legal action against the pharmaceutical titan, arguing the 'defective' jab was to blame for their injuries and deaths of loved ones.

Lawyers involved in the huge legal battle think some victims could be in line for pay-outs worth up to £5million.

As such, the total compensation bill – which would be footed by taxpayers because of a deal AstraZeneca struck with the Government before the roll-out commenced – could theoretically reach £255m, if judges were to rule the vaccine was to blame for all of the injuries and deaths involved in the class action.

However, claims have yet to be fully quantified and some cases could eclipse or fall much short of the estimated £5million.

Some might not be proven to be down to the vaccine, which was given to millions of Britons. Deadly side effects were extraordinarily rare.

The revelation at the potential compensation bill comes after AstraZeneca admitted – for the first time – that its vaccine could cause a blood clotting syndrome linked to some of the lawsuits.

Cambridge-based AstraZeneca, which is contesting the legal battle, acknowledged in a legal document submitted to the High Court in February that its vaccine 'can, in very rare cases, cause TTS'.

TTS is short for thrombosis with thrombocytopenia syndrome – a medical condition where a person suffers blood clots along with a low platelet count. Platelets typically help the blood to clot.

AstraZeneca's admission could lead to pay-outs on a case-by-case basis.

Join The Conversation. Leave a Comment.


We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.